| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | Director | Chief Operating Officer
3 companies
McFarlane Neil F. is a President And CEO at ZEVRA THERAPEUTICS, INC. with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $5.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 10, 2025 | ZVRA Zevra Therapeutics, Inc. | President And CEO | Sale+OE | 19,500 | $10.82 | $210,908.10 | -8.1% | -21.6% | - | |
| Feb 14, 2025 | ZVRA Zevra Therapeutics, Inc. | President And CEO | Sell | 91,817 | $7.92 | $727,389.76 | -18.2% | +4.5% | +5.3% | |
| May 16, 2019 | TVTX Travere Therapeutics, Inc. | Chief Operating Officer | Sell | 1,968 | $18.25 | $35,906.16 | -3.5% | - | - | |
| Dec 20, 2018 | TVTX Travere Therapeutics, Inc. | Chief Operating Officer | Sell | 11,125 | $22.32 | $248,333.18 | -14.7% | - | - | |
| Nov 14, 2018 | TVTX Travere Therapeutics, Inc. | Chief Operating Officer | Sell | 10,000 | $23.73 | $237,314.40 | -14.7% | - | - | |
| Aug 16, 2017 | TVTX Travere Therapeutics, Inc. | Chief Operating Officer | Sell | 1,378 | $22.50 | $31,005.00 | -9.2% | - | - |